HUNMEDIUM SIGNALFINANCIAL10-K

Huntsman's net losses expanded meaningfully while the company strengthened its cash position and reduced inventory levels.

The widening net loss suggests operational headwinds or one-time charges that warrant investor scrutiny, though the improved cash position provides some financial flexibility. The inventory reduction could signal either demand weakness or improved working capital management, requiring further analysis of underlying business conditions.

Comparing 2026-02-18 vs 2025-02-18View on EDGAR →
FINANCIAL ANALYSIS

Huntsman faced financial challenges with net losses expanding meaningfully to $284 million and gross profit declining 13.3% to $751 million. However, the company improved its liquidity position with cash and equivalents growing 26.2% to $429 million while reducing inventory by 10.8% to $818 million. The mixed financial picture suggests operational pressures offset partially by better working capital management and stronger cash reserves.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-50.3%
-$189.0M→-$284.0M

Net income declined 50.3% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
+26.2%
$340.0M→$429.0M

Cash grew 26.2% — improving liquidity position supports investment and shareholder returns.

Gross Profit
P&L
-13.3%
$866.0M→$751.0M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Inventory
Balance Sheet
-10.8%
$917.0M→$818.0M

Inventory reduced 10.8% — lean inventory management or demand outpacing supply.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-18
ADDED
Segment adjusted EBITDA is the measure that our chief operating decision maker ( CODM ), who has been determined to be our Chief Executive Officer, uses to make decisions about resources to be allocated to the segments and assess their financial performance.
Our CODM evaluates segment adjusted EBITDA through the annual budget process as well as through ongoing periodic reviews of forecasts, budget-to-actual variances, changes from prior periods and when comparing the results of each reportable operating segment with one another.
Total operating lease expense includes short-term lease expense of approximately $1 million, $1 million and $3 million for the years ended December 31, 2023, 2022 and 2021, respectively.
Amounts contain approximately nil, nil and $1 million of prior service credit and actuarial loss related to discontinued operations for the years ended December 31, 2025, 2024 and 2023, respectively.
Other segment items include other operating and non-operating income and expense items and foreign currency exchange effects, less adjustments to remove the related effects of primarily the following items: business acquisition and integration gain (expenses) and purchase accounting inventory adjustments, net; certain legal and other settlements and related income (expenses), net; amortization of pension and postretirement actuarial losses; loss on sale of business/assets; and restructuring, impairment and plant closing and transition costs.
+7 more — sign up free →
REMOVED
Other segment items include other operating and non-operating income and expense items and foreign currency exchange effects.
A total of 191,959 performance share unit awards with a grant date fair value of $45.04 that were included in the December 31, 2023 nonvested balance did not meet the minimum performance criteria of these awards and were effectively forfeited during the first quarter of 2024.
Amounts are net of tax of $91 million and $55 million as of December 31, 2023 and January 1, 2023, respectively.
Certain legal and other settlements and related expenses for the year ended December 31, 2024 includes approximately $10 million related to the settlement of a claim in connection with a commercial dispute.
The representative interest rate as of December 31, 2024 was 1.475% above Term SOFR.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →